Harbin Sanlian Pharmaceutical (002900.SZ) released its first three quarters performance, with a net loss attributable to shareholders of RMB 94.2949 million.

Zhitong Finance APP News, Hualan (002900.SZ) released its 2026 third-quarter report. In the first three quarters, the company achieved operating revenue of 623 million yuan, a year-on-year increase of 7.32%; net loss attributable to shareholders of the listed company was 94.2949 million yuan; net loss attributable to shareholders of the listed company after deducting non-recurring gains and losses was 108 million yuan; basic earnings per share was -0.3 yuan.